Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation

BACKGROUND. The purpose of this study was to identify determinants of renal disease progression in adults with Fabry disease during treatment with agalsidase beta. METHODS. Renal function was evaluated in 151 men and 62 women from the Fabry Registry who received agalsidase beta at an average dose of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Warnock, David G., Ortiz, Alberto, Mauer, Michael, Linthorst, Gabor E., Oliveira, João P., Serra, Andreas L., Maródi, László, Mignani, Renzo, Vujkovac, Bojan, Beitner-Johnson, Dana, Lemay, Roberta, Cole, J.Alexander, Svarstad, Einar, Waldek, Stephen, Germain, Dominique P., Wanner, Christoph
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2012
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3289896/
https://ncbi.nlm.nih.gov/pubmed/21804088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfr420
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki